News & Events
June 22-24, 2023
EVF Annual Meeting, Berlin, Germany
The objective of EVF is to develop education, scientific knowledge, research and clinical expertise of the highest quality and establish standards in the field of venous disease.
Latest news 2023:
Happy to announce another European patent approval!
The PressCise owned patent “A kit and therapeutic pressure assembly with patches for applying pressure to a limb or other body part” was approved by the European Patent Office (EPO).
The patent covers the products PressPatch™ and FixPatch™ which are part of the Lundatex® system – a compression product maintaining a low, safe resting pressure and a high effective working pressure.
Lundatex® compression products recognized as “trail blazers”!
In December 2022 PressCise innovative Lundatex® compression products were selected to be on Life Science Sweden's innovation list, among a selection of “trail blazers”. The selected products are based on Swedish technology developed in the last half century, aiming to improve people’s health.
The following text is a translation of the announcement published on Life Science Sweden's website:
“Lundatex® compression products, such as bandages, stockings and compression systems, are primarily used to treat venous and lymphatic leg diseases, such as hard-to-heal leg ulcers. The idea to develop a "smart bandage" came from Erney Mattsson, professor of vascular surgery at Sahlgrenska Academy the faculty of medicine at the University of Gothenburg, and Torbjörn Lundh, professor of mathematics at Chalmers University of Technology. Through the University of Textiles and Smart Textiles in Borås, they came into contact with the textile developer, Josefin Damm. Together, the three were able to develop the products that make it possible for healthcare professionals to apply bandages with the correct pressure.
The company PressCise, applied for its first patent in 2013 and since then, four additional products have been patented. The products are now being more frequently used, and have the potential to reach the global market – to the benefit of many patients.”
November 30, 2022
Park Annual, Gothenburg, Sweden
PressCise's CEO Andreas Nilsson attended the annual life science event in Western Sweden!
"A life science event with inspiration, thought-provoking presentations, future trends and pioneering ideas."
November 14-17, 2022
MEDICA tradefair, Düsseldorf, Germany
CEO Andreas Nilsson and CTO/Co-Inventor Josefin Damm attended the world’s largest tradefair for the medical industry. A large and busy event presenting a great opportunity to meet up with old and new friends from the industry!
October 27-28, 2022
Wound Healing Society Scientific Inaugural Meeting: Biophysical Control of Wound Healing - Science of Healing of Wounds, Sacramento, California
Inventor Professor Torbjörn Lundh presented his mathematical work on
"How wound shape alters healing"
Thursday, October 27, 8:40 - 9:00 am.
October 13-16, 2022
AVLS 36th Annual Congress,
New Orleans, Louisiana, USA
CEO Andreas Nilsson and CTO/Co-inventor Josefin Damm attended the great event, organized by the American Vein & Lymphatic Society.
September 12-16, 2022:
UIP World Congress of Phlebology,
PressCise management was attending the World Congress of the International Union of Phlebology (UIP), where CEO Andreas Nilsson, Ph.D presented the abstract entitled:
"Avoid Inconclusive Outcomes from Compression Studies"
Tuesday, September 13, 2022 / 13:30-15:00
Abstract Session 3 [English], Sagalassos Hall
For more information about the event, including information on Dr. Nilsson's presentation, please visit the event website at: https://www.uip2022.org/
PressCise is listed on IVA's Top 100 List 2022!
PressCise was listed on the Royal Swedish Academy of Engineering Science's (IVA) Top 100 List of companies judged to be employing technology in the service of humanity for commercial benefit and societal impact.
You can read more about IVA on the Royal Swedish Academy of Engineering Science's website here: https://www.iva.se/en/About-IVA/what-is-iva/
April - May 2022
PressCise is back on the road! Management attends various global conferences
As the world has begun to open back up in post-Covid times, PressCise's management team has been able to hit the road again and attend various international conferences this spring.
Among them were the SSiS Wound Conference (Gävle, Sweden; April 2022), OTWorld Trade Show (Leipzig, Germany; May 2022), ECoP: European College of Phlebology Course (Amsterdam, Netherlands; May 2022) and the ICC Meeting (Amsterdam, Netherlands; May 2022).
We're so excited for the 2022 event calendar that lies ahead. Check out our upcoming event schedule if you'd like to meet up!!
PressCise presents at WUWHS 2022!
PressCise's CEO Andreas Nilsson, Ph. D and professor Torbjörn Lundh will be giving an in-person presentation entitled, "SELF-CARE AND FITTING OF NEW ‘SMART-TEXTILE’
COMPRESSION STOCKING” at the WUWHS 2022 Hybrid-Congress in Abu Dhabi from 1-5 March. The presentation itself takes place in the block of time between 2:30-3:45pm on Wednesday, March 2.
We hope to see you there!
PressCise adds another patent to its portfolio!
PressCise's Lundatex® medical bandage is now patent-protected in the EU under the filing Elastic bandage and textile material for use in such an elastic bandage (Patent no. WO 2015/007335), described in part as "An elastic bandage...enabling the bandage to be applied with improved ease, predictability and controllability, even on body parts having variable circumference."
PressCise presents at EWMA 2022
PressCise CEO Andreas Nilsson, Ph.D gave two presentations at the European Wound Management Association's 2022 conference. The presentations were entitled:
1. "Compression treatment with controlled pressure in combination with novel wound dressing may improve patient self-care and reduce hospital visits"
2. "Feasability study with a new microtransplant device and controlled compression treatment"